7 years ago
Medopad Secures US$26M in First Close of Series A Funding
Medopad, a London-based healthtech AI company, secured US$26m in the first close of its Series A funding
The company aims to raise a total of US$120m and has entered into strategic partnerships with leading healthcare and technology institutions.
ProblemHealthcare
" Healthcare providers lack real-time data about patients, making it difficult to detect health issues early and provide proactive care. This leads to higher healthcare costs and less efficient use of resources."
Solution
" Medopad provides a healthcare technology platform that connects patients and healthcare professionals in real time. Patients can use their smartphones, smart watches, and other connected devices to capture data about their health. The data is then analyzed by Medopad's AI / Machine Learning capabilities to generate insights that can help detect life-threatening medical conditions early. This enables proactive early intervention, generates operational efficiencies, and drives cost savings."
